| RS2529015935 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2529017348 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency 3, MHC class II deficiency 3 |
| RS2529019322 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2529019649 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2529019979 |
LARS2
|
Health Risk |
Pathogenic |
— |
| RS2529020120 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2529024443 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2529027871 |
RFX5
|
Health Risk |
Likely pathogenic |
— |
| RS2529028222 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2529029548 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529029832 |
MSH2
|
Health Risk |
Likely pathogenic |
Uterine corpus cancer, Uterine corpus cancer |
| RS2529029888 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529030066 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS2529030821 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529031441 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS2529031670 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529031745 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529031932 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529032039 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529032145 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529032801 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS2529033343 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2529033786 |
PPP1R21
|
Health Risk |
Pathogenic |
— |
| RS2529033839 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529034008 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS2529034041 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529034182 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529034279 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529034729 |
SOS1
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS2529034770 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome 4 |
| RS2529035233 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529035887 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529036705 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529036790 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529036943 |
SOS1
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome |
| RS2529037106 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529037375 |
SOS1
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2529037472 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529037535 |
SOS1
|
Health Risk |
Likely pathogenic |
— |
| RS2529037723 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2529037843 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2529037917 |
SOS1
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS2529037981 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2529038228 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529038601 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529038959 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529039115 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529039319 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529040143 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529040595 |
RFX5
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2529040601 |
FYCO1
|
Health Risk |
Pathogenic |
Cataract 18, Cataract 18 |
| RS2529044401 |
PPP1R21
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, facial dysmorphism |
| RS2529047720 |
RFX5
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2529048000 |
RFX5
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2529057646 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2529061466 |
KIF15
|
Health Risk |
Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis |
| RS2529069818 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529069953 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529070364 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2529071300 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2529071921 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2529075615 |
MSH2
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2529086363 |
EIF2AK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529089802 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529097896 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
— |
| RS2529098558 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529098711 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529100401 |
DPH2
|
Health Risk |
Likely pathogenic |
Developmental delay with short stature, dysmorphic facial features |
| RS2529102620 |
LARS2
|
Health Risk |
Likely pathogenic |
Perrault syndrome 4, Perrault syndrome 4 |
| RS2529107216 |
ACAD9
|
Health Risk |
Pathogenic |
— |
| RS2529107245 |
ACAD9
|
Health Risk |
Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2529107282 |
ACAD9
|
Health Risk |
Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2529107329 |
ACAD9
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, Mitochondrial complex I deficiency |
| RS2529107343 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2529109507 |
ANO10
|
Health Risk |
Pathogenic |
— |
| RS2529110370 |
ANO10
|
Health Risk |
Pathogenic |
— |
| RS2529116929 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529117164 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529117319 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
— |
| RS2529117612 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2529118686 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2529126093 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529126807 |
EIF2AK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529127466 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529128780 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529129420 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529132935 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529133062 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529140086 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529140205 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529140255 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529148991 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529155350 |
PSMB4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2529157085 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529165321 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529165492 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529165633 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2529170080 |
DCTN1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Perry syndrome |
| RS2529171218 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2529171945 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |